Rising Cancer Prevalence Fuels Surge In Demand For Targeted Therapy Driver: Leading Transformation in the Targeted Therapy Market in 2025

What industry-specific factors are fueling the growth of the targeted therapy market?
The escalating incidence of cancer is projected to boost the expansion of the targeted therapy market. Cancer refers to a group of diseases in which rogue cells invade neighboring tissues and multiply without inhibition. Targeted therapy can interrupt the signals that stimulate the growth of cancer cells or direct these cells towards a path of self-destruction. It utilizes drugs that are designed to specifically target genes and proteins that nurture the growth and endurance of these cancer cells thereby, raising its demand. For example, as per the American Cancer Society, a US-based charitable organization devoted to cancer advocacy, there was a surge in cancer cases to 2,001,140 in January 2024, in contrast to 1,958,310 in 2023, showing a 2.19% growth. Hence, the rising occurrence of cancer is likely to fuel the growth of the targeted therapy market.

Get Your Targeted Therapy Market Report Here:
https://www.thebusinessresearchcompany.com/report/targeted-therapy-global-market-report

What Is the projected market size and growth rate for the targeted therapy market?
The market size for targeted therapy has seen substantial growth in recent years. It is forecasted to increase from $103.84 billion in 2024 to $111.47 billion in 2025, experiencing a compound annual growth rate (CAGR) of 7.3%. The growth during the historical period is due to developments in molecular biology, a rise in cancer instances, the trend towards personalized medicine, approvals by the FDA, and regulatory assistance.

Significant expansion is projected for the targeted therapy market size in the upcoming years, with an anticipated increase to $151.48 billion by 2029, at a compound annual growth rate (CAGR) of 8.0%. This estimated growth during the forecast period is driven by factors such as growing oncology studies, increased demand for precision medicine, the advent of immunotherapies, increased financing in biopharmaceuticals, and heightened patient awareness and advocacy. Major emerging trends during this forecast period comprise the incorporation of artificial intelligence (AI) in drug discovery, patient advocacy and their increased participation in treatment decisions, broader application of companion diagnostics, regulatory backing for faster approvals and a surge in biotechnology and pharmaceutical investing.

Get Your Free Sample Now - Explore Exclusive Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=9129&type=smp

What new trends are reshaping the targeted therapy market and its opportunities?
Leading entities in the targeted therapy market are striving to build robust technological solutions to solidify their market positioning. For example, in March 2022, multinational pharmaceutical corporation Novartis AG, headquartered in Switzerland, introduced Pluvicto, a product that received approval from the US Food and Drug Administration (FDA). This makes Pluvicto the first targeted radioligand therapy (RLT) for patients eligible with mCRPC, approved by the FDA. Essentially, Pluvicto is a type of targeted cancer therapy that amalgamates a therapeutic radioisotope with a specific chemical (a radioactive particle). Pluvicto attaches to targeted cells in the bloodstream, particularly prostate cancer cells that manifest the PSMA transmembrane protein. Upon bonding, the energy discharge from the radioisotope damages the targeted cells and nearby cells, thus obstructing their replication and/or causing cell death.

What major market segments define the scope and growth of the targeted therapy market?
The targeted therapy market covered in this report is segmented -

1) By Type: Small Molecule Medicines, Monoclonal Antibodies
2) By Distribution Channel: Hospital Pharmacies, Retail Pharmacies, Online Pharmacies
3) By Application: Breast Cancer, Colorectal Cancer, Leukemia, Lung Cancer, Lymphoma, Renal Cancer, Other Applications

Subsegments:
1) By Small Molecule Medicines: Tyrosine Kinase Inhibitors (TKIs), Proteasome Inhibitors, Phosphatidylinositol 3-Kinase (PI3K) Inhibitors, Other Small Molecule Therapies
2) By Monoclonal Antibodies: Immune Checkpoint Inhibitors, Antibody-Drug Conjugates (ADCs), Cytokine Blockers, Other Monoclonal Antibodies

Unlock Exclusive Market Insights - Purchase Your Research Report Now!
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=9129

Which region dominates the targeted therapy market?
North America was the largest region in the targeted therapy market in 2024. The regions covered in the targeted therapy market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Which key market leaders are driving the targeted therapy industry growth?
Major companies operating in the targeted therapy market include Pfizer Inc., Johnson & Johnson, F. Hoffmann-La Roche Ltd, Merck & Co Inc., AbbVie Inc., Bayer AG, Novartis AG, Sanofi SA, Bristol Myers Squibb, AstraZeneca, GlaxoSmithKline plc, Takeda Pharmaceutical Company Limited, Eli Lilly and Company, Gilead Sciences Inc., Amgen Inc., Genmab A/S, Regeneron Pharmaceuticals Inc., Biogen Inc., Vertex Pharmaceuticals Incorporated, Agilent Technologies Inc., Illumina Inc., Incyte Corporation, Sysmex Corporation, Exact Sciences Corporation, Seagen Inc., Exelixis Inc., Seattle Genetics Inc., Genentech Inc., Daiichi Sankyo Company Limited

Customize Your Report - Get Tailored Market Insights!
https://www.thebusinessresearchcompany.com/customise?id=9129&type=smp

What Is Covered In The Targeted Therapy Global Market Report?

•Market Size Forecast: Examine the targeted therapy market size across key regions, countries, product categories, and applications.
•Segmentation Insights: Identify and classify subsegments within the targeted therapy market for a structured understanding.
•Key Players Overview: Analyze major players in the targeted therapy market, including their market value, share, and competitive positioning.
•Growth Trends Exploration: Assess individual growth patterns and future opportunities in the targeted therapy market.
•Segment Contributions: Evaluate how different segments drive overall growth in the targeted therapy market.
•Growth Factors: Highlight key drivers and opportunities influencing the expansion of the targeted therapy market.
•Industry Challenges: Identify potential risks and obstacles affecting the targeted therapy market.
•Competitive Landscape: Review strategic developments in the targeted therapy market, including expansions, agreements, and new product launches.

Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.

Contact Us
Europe: +44 207 1930 708,
Asia: +91 88972 63534,
Americas: +1 315 623 0293 or
Email: mailto:info@tbrc.info

Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.